Jesse Wiley of Sage Bionetworks talks about his involvement with TREAT-AD, which is an exciting open-science, community approach to developing data-drive hypotheses that may lead towards new kinds of treatments for Alzheimer's disease. These new approaches will go beyond the amyloid hypothesis that has dominated research and drug development approaches over the last two decades, yet failed to produce any effective drug.